Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.

Campbell JD, Yau C, Bowlby R, Liu Y, Brennan K, Fan H, Taylor AM, Wang C, Walter V, Akbani R, Byers LA, Creighton CJ, Coarfa C, Shih J, Cherniack AD, Gevaert O, Prunello M, Shen H, Anur P, Chen J, Cheng H, Hayes DN, Bullman S, Pedamallu CS, Ojesina AI, Sadeghi S, Mungall KL, Robertson AG, Benz C, Schultz A, Kanchi RS, Gay CM, Hegde A, Diao L, Wang J, Ma W, Sumazin P, Chiu HS, Chen TW, Gunaratne P, Donehower L, Rader JS, Zuna R, Al-Ahmadie H, Lazar AJ, Flores ER, Tsai KY, Zhou JH, Rustgi AK, Drill E, Shen R, Wong CK, Cancer Genome Atlas Research Network, Stuart JM, Laird PW, Hoadley KA, Weinstein JN, Peto M, Pickering CR, Chen Z, Van Waes C
Cell Rep. 2018 23 (1): 194-212.e6

PMID: 29617660 · PMCID: PMC6002769 · DOI:10.1016/j.celrep.2018.03.063

MeSH Terms (10)

Carcinoma, Squamous Cell Cell Line, Tumor DNA Methylation Epithelial-Mesenchymal Transition Gene Expression Regulation, Neoplastic Genomics Genomics Humans Metabolic Networks and Pathways Polymorphism, Genetic

Connections (1)

This publication is referenced by other Labnodes entities:

Links